Skip to content
10-K

Annual Report

ADAPTIN BIO, INC. APTN

0001213900-26-038568

← back to feed
Filed
Apr 1, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 26, 2026 8.79M sh
Shares Diluted FY 2025 · Dec 31, 2025 7.81M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 3.25M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$4.78M
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$649.28K
Cash And Equivalents FY 2025 · Dec 31, 2025 $459.17K
Cash And Equivalents FY 2025 · Dec 31, 2024 $34.09K
Stockholders Equity FY 2025 · Dec 31, 2025 −$1.49M
Stockholders Equity restated FY 2025 · Dec 31, 2024 −$4.1M
Stockholders Equity restated FY 2025 · Dec 31, 2023 −$977.56K
Current Liabilities FY 2025 · Dec 31, 2025 $2.11M
Current Liabilities restated FY 2025 · Dec 31, 2024 $4.34M
Total Liabilities FY 2025 · Dec 31, 2025 $2.11M
Total Liabilities restated FY 2025 · Dec 31, 2024 $4.34M
Current Assets FY 2025 · Dec 31, 2025 $619.16K
Current Assets restated FY 2025 · Dec 31, 2024 $45.54K
Total Assets FY 2025 · Dec 31, 2025 $619.16K
Total Assets restated FY 2025 · Dec 31, 2024 $239.42K
Eps Diluted FY 2025 · Dec 31, 2025 −$0.66
Eps Diluted restated FY 2025 · Dec 31, 2024 −$0.96
Eps Basic FY 2025 · Dec 31, 2025 −$0.66
Eps Basic restated FY 2025 · Dec 31, 2024 −$0.96
Sga Expense FY 2025 · Dec 31, 2025 $3.64M
Sga Expense restated FY 2025 · Dec 31, 2024 $745.29K
Rd Expense FY 2025 · Dec 31, 2025 $1.77M
Rd Expense FY 2025 · Dec 31, 2024 $1.82M
Net Income FY 2025 · Dec 31, 2025 −$5.17M
Net Income restated FY 2025 · Dec 31, 2024 −$3.12M
Operating Income FY 2025 · Dec 31, 2025 −$5.41M
Operating Income restated FY 2025 · Dec 31, 2024 −$2.57M